Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-22-046569
Filing Date
2022-12-21
Accepted
2022-12-21 21:32:36
Documents
1
Period of Report
2022-12-19

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 5514
  Complete submission text file 0001140361-22-046569.txt   6875
Mailing Address C/O TOBIRA THERAPEUTICS, INC. 701 GATEWAY BOULEVARD, #200 SOUTH SAN FRANCISCO CA 94080
Business Address
Lefebvre Eric (Reporting) CIK: 0001614741 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39303 | Film No.: 221479619

Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 650-481-6770
PLIANT THERAPEUTICS, INC. (Issuer) CIK: 0001746473 (see all company filings)

EIN.: 474272481 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations